Covington Capital Management Has Decreased Cvs Health (CVS) Position By $448,704; Last Week Monsanto Company (MON) Coverage

April 17, 2018 - By Richard Conner

CVS Health Corporation (NYSE:CVS) Logo

Covington Capital Management decreased Cvs Health Corp (CVS) stake by 8.03% reported in 2017Q4 SEC filing. Covington Capital Management sold 6,232 shares as Cvs Health Corp (CVS)’s stock declined 17.45%. The Covington Capital Management holds 71,340 shares with $5.17 million value, down from 77,572 last quarter. Cvs Health Corp now has $68.17 billion valuation. The stock increased 1.46% or $0.97 during the last trading session, reaching $67.07. About 8.23 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since April 17, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

Among 23 analysts covering Monsanto Company (NYSE:MON), 10 have Buy rating, 1 Sell and 12 Hold. Therefore 43% are positive. Monsanto Company had 63 analyst reports since August 25, 2015 according to SRatingsIntel. The stock of Monsanto Company (NYSE:MON) earned “Hold” rating by Jefferies on Monday, August 14. Atlantic Securities upgraded Monsanto Company (NYSE:MON) on Tuesday, December 1 to “Overweight” rating. The company was downgraded on Friday, May 27 by Atlantic Securities. BMO Capital Markets maintained Monsanto Company (NYSE:MON) rating on Wednesday, June 28. BMO Capital Markets has “Buy” rating and $12800 target. The stock of Monsanto Company (NYSE:MON) earned “Underperform” rating by Bernstein on Friday, September 11. The firm has “Buy” rating given on Wednesday, May 25 by Jefferies. On Thursday, January 7 the stock rating was maintained by Barclays Capital with “Equal Weight”. RBC Capital Markets maintained it with “Hold” rating and $128.0 target in Monday, October 9 report. The rating was maintained by Citigroup with “Neutral” on Monday, August 22. The stock has “Neutral” rating by Citigroup on Thursday, April 7. See Monsanto Company (NYSE:MON) latest ratings:

16/04/2018 Broker: Argus Research Old Rating: Buy New Rating: Sell Downgrade
09/04/2018 Broker: BMO Capital Markets Rating: Hold New Target: $128.0000 Downgrade
17/01/2018 Broker: Wells Fargo Rating: Hold New Target: $128.0 Maintain
13/11/2017 Broker: RBC Capital Markets Rating: Hold New Target: $128.0 Maintain

Investors sentiment decreased to 0.72 in Q4 2017. Its down 0.16, from 0.88 in 2017Q3. It worsened, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. Amp Cap holds 0.25% or 631,477 shares. Ing Groep Nv invested in 92,024 shares. Cacti Asset Mngmt Lc owns 3.22% invested in CVS Health Corporation (NYSE:CVS) for 548,308 shares. Adams Diversified Equity Fund accumulated 174,800 shares or 0.68% of the stock. Cibc Natl Bank Usa holds 0.07% or 7,886 shares in its portfolio. Amg Natl Bancorporation holds 0.13% or 27,002 shares in its portfolio. Mercer Cap Advisers Inc stated it has 0.08% of its portfolio in CVS Health Corporation (NYSE:CVS). Moreover, Selway Asset Management has 2.17% invested in CVS Health Corporation (NYSE:CVS) for 50,978 shares. Roundview Cap Ltd Liability Corporation, New Jersey-based fund reported 6,815 shares. St Johns Mgmt Co Limited Liability Company holds 0.7% or 13,079 shares. Chem Comml Bank has 0.33% invested in CVS Health Corporation (NYSE:CVS) for 42,067 shares. Wellington Grp Inc Ltd Liability Partnership accumulated 22.57 million shares. Sawgrass Asset reported 0.09% in CVS Health Corporation (NYSE:CVS). Northstar reported 21,957 shares. Santa Barbara Asset Management Ltd Liability Corporation holds 1.99M shares or 2.18% of its portfolio.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on May, 2 before the open. They expect $1.40 earnings per share, up 19.66% or $0.23 from last year’s $1.17 per share. CVS’s profit will be $1.42B for 11.98 P/E if the $1.40 EPS becomes a reality. After $1.92 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts -27.08% negative EPS growth.

Since February 16, 2018, it had 0 buys, and 1 insider sale for $1.42 million activity. The insider Foulkes Helena sold $1.42 million.

Covington Capital Management increased Celgene Corp (NASDAQ:CELG) stake by 15,515 shares to 107,898 valued at $11.26 million in 2017Q4. It also upped Flaherty&Crmn Pfd Sec In (FFC) stake by 20,733 shares and now owns 405,383 shares. Paccar Inc (NASDAQ:PCAR) was raised too.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 75 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was maintained by JP Morgan on Monday, November 2 with “Overweight”. As per Friday, September 8, the company rating was maintained by Needham. Loop Capital maintained CVS Health Corporation (NYSE:CVS) on Tuesday, November 7 with “Hold” rating. The stock has “Hold” rating by Jefferies on Monday, December 12. The stock has “Buy” rating by Jefferies on Thursday, May 12. The firm has “Hold” rating by Deutsche Bank given on Wednesday, July 22. Wolfe Research downgraded CVS Health Corporation (NYSE:CVS) on Wednesday, August 16 to “Hold” rating. The company was maintained on Monday, November 2 by S&P Research. The firm has “Neutral” rating by Goldman Sachs given on Thursday, December 17. As per Tuesday, November 7, the company rating was maintained by Jefferies.

Since October 19, 2017, it had 0 insider purchases, and 1 sale for $966,720 activity. Shares for $527,040 were sold by Courduroux Pierre on Thursday, October 19. MIZELL STEVEN sold 8,100 shares worth $966,720.

Investors sentiment decreased to 0.81 in 2017 Q4. Its down 0.03, from 0.84 in 2017Q3. It turned negative, as 69 investors sold Monsanto Company shares while 328 reduced holdings. 75 funds opened positions while 246 raised stakes. 317.44 million shares or 1.24% less from 321.42 million shares in 2017Q3 were reported. First Manhattan Communication stated it has 1,137 shares. South Dakota Council reported 235,135 shares. The Massachusetts-based Loring Wolcott & Coolidge Fiduciary Limited Liability Partnership Ma has invested 0.02% in Monsanto Company (NYSE:MON). 45,681 are held by Profund Advsr Limited Liability Co. 11.71 million were reported by Berkshire Hathaway. First Fin In, a Indiana-based fund reported 1,652 shares. State Treasurer State Of Michigan owns 528,763 shares or 0.49% of their US portfolio. Johnson Fincl Grp holds 0% in Monsanto Company (NYSE:MON) or 34 shares. Comml Bank Of Montreal Can reported 1.04 million shares. Franklin Resources holds 4.97M shares or 0.28% of its portfolio. 1.26M were accumulated by Canyon Capital Advsr Llc. Blackrock stated it has 0.15% in Monsanto Company (NYSE:MON). Castleark Mngmt Lc holds 0.02% or 6,120 shares in its portfolio. Nelson Roberts Lc holds 460 shares. 176,733 are owned by Penn Davis Mcfarland.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>